PAF-acether and acetylhydrolase in stool of patients with Crohn's disease

Digestive Diseases and Sciences

Volumn 37, Issue 3, 1992, Pages 432-437

  Denizot, Y ^a,b,c,d   Chaussade, S ^a,b,c,d   Nathan, N ^a,b,c,d   Colombel, J F ^a,b,c,d   Bossant, M J ^a,b,c,d   Cherouki, N ^a,b,c,d   Benveniste, J ^a,b,c,d   Couturier, D ^a,b,c,d  

^a INSERM   (France)

^b Hôpital Cochin ^*  (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

acetylhydrolase; Crohn's disease; PAF acether; stool

Indexed keywords

ACETYL HYDROLASE; AZATHIOPRINE; GINKGOLIDE B; PREDNISOLONE; SALAZOSULFAPYRIDINE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FECES; FEMALE; HUMAN; IRRITABLE COLON; MALABSORPTION; MALE; PRIORITY JOURNAL;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLONIC DISEASES, FUNCTIONAL; CROHN DISEASE; DIARRHEA; FECES; FEMALE; HUMAN; MALABSORPTION SYNDROMES; MALE; MIDDLE AGE; PHOSPHOLIPASES A; PLATELET ACTIVATING FACTOR; SUPPORT, NON-U.S. GOV'T;

EID: 0026572039     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/BF01307739     Document Type: Article

References (26)

1. PAF-acether, an ether phospholipid with biological activity
2. Platelet-activating factors
3. Potent ulcerogenic actions of platelet-activating factor
4. Experimental model of ischemic bowel necrosis: The role of platelet-activating factor and endotoxin
5. Hypoxia causes ischemic bowel necrosis in rats: the role of platelet-activating factor
6. Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone
7. Novel aspect of Crohn's disease: Increased content of platelet-activating factor in ileal and colonic mucosa
8. Occurrence of platelet-activating factor (PAF) in normal rat stomach and alteration of PAF level by water immersion stress
9. Human plasma platelet-activating factor acetylhydrolase. Purification and properties
10. Presence of PAF in stool of patients with pouch ileo-anal anastomosis and pouchitis
11. Presence of PAF-acether in stool of patients with infectious diarrhea
12. Presence of PAF-acether in stools of patients suffering from inflammatory bowel disease
13. Release, purification, and characterization of platelet-activating factor (PAF)
14. Solid-phase extraction on silica cartridges as an aid to platelet-activating factor enrichment and analysis
15. A simple index of Crohn's disease activity
16. Biosynthesis of PAF-acether (plateletactivating factor). VII. Precursors of PAF-acether and acetylhydrolase activity in human leukocytes
17. Aggregation of rabbit platelets by platelet-activating factor is independent of the release reaction and the arachidonate pathway and inhibited by membrane active drugs
18. 3H]PAF-acether from, and inhibits its binding to intact human platelets
19. Structural analysis of purified platelet-activating factor by lipases
20. PAF as an activity marker in Crohn's disease
21. Synthesis of PAF-acether from exogenous precursors by the prokaryote Escherichia coli
22. PAF-acether synthesis by Helicobacter pylori
23. 2
24. 2 activity of ileal mucosa in Crohn's disease
25. 2 activity of colonic mucosa in Crohn's colitis
26. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators